Robert B. Huizinga

Robert B. Huizinga

Chairman chez KANE BIOTECH INC.

59 ans
Consumer Services
Health Services
Commercial Services

Profil

Robert B.
Huizinga
is the founder of Renalpro.
He currently holds the position of Executive Chairman at Kane Biotech, Inc. and is a Director at Biovialife, Inc. He is also a Member of Sigma Theta Tau International Honor Society of Nursing, Inc. and serves as the Principal at Reformation Consulting Services, Inc. Previously, he served as an Independent Director at Innovotech, Inc. from 2013 to 2016.
Prior to that, he was the Vice President-Clinical Affairs at Isotechnika Pharma, Inc. from 2002 to 2013.
He also held the position of Executive Vice President-Research at Aurinia Pharmaceuticals, Inc. from 2020 to 2022.
Dr. Huizinga obtained a doctorate degree from Regent University and a graduate degree from the University of Alberta.

Postes actifs de Robert B. Huizinga

SociétésPosteDébut
KANE BIOTECH INC. Chairman 20/02/2024
Corporate Officer/Principal -
Director/Board Member -
Tous les postes actifs de Robert B. Huizinga

Anciens postes connus de Robert B. Huizinga

SociétésPosteFin
AURINIA PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer 31/10/2022
INNOVOTECH INC. Director/Board Member 08/11/2016
Chief Tech/Sci/R&D Officer 23/10/2013
Renalpro Founder -
Voir l'expérience en détail de Robert B. Huizinga

Formation de Robert B. Huizinga

Regent University Doctorate Degree
University of Alberta Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Robert B. Huizinga

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
INNOVOTECH INC.

Health Services

KANE BIOTECH INC.

Commercial Services

AURINIA PHARMACEUTICALS INC.

Health Technology

Entreprise privées4

Health Services

Health Technology

Commercial Services

Renalpro

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Robert B. Huizinga